Difference between revisions of "Team:Edinburgh/Description"

 
(56 intermediate revisions by 4 users not shown)
Line 1: Line 1:
{{Edigem15_Design}}
+
{{Edigem15_Overview}}
 
<html>
 
<html>
  
Line 7: Line 7:
 
<script src="https://maxcdn.bootstrapcdn.com/bootstrap/3.3.5/js/bootstrap.min.js"></script>
 
<script src="https://maxcdn.bootstrapcdn.com/bootstrap/3.3.5/js/bootstrap.min.js"></script>
 
     </head>
 
     </head>
 +
  <!-- menu -->
 +
<div id="custom-bootstrap-menu" class="navbar navbar-default navbar-fixed-top" role="navigation">
 +
    <div class="container-fluid">
 +
        <div class="navbar-header">
 +
            <button type="button" class="navbar-toggle" data-toggle="collapse" data-target=".navbar-menubuilder"><span class="sr-only">Toggle navigation</span><span class="icon-bar"></span><span class="icon-bar"></span><span class="icon-bar"></span>
 +
            </button>
 +
        </div>
 +
        <div class="collapse navbar-collapse navbar-menubuilder">
 +
            <ul class="nav navbar-nav navbar-right">
 +
              <li class="active">
 +
                  <a href="https://2015.igem.org/Team:Edinburgh">Home</a></li>
 +
                  <li class="dropdown">
 +
                    <a href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" aria-expanded="false">About<span class="caret"></span></a>
 +
                    <ul class="dropdown-menu" role="menu">
 +
                      <li><a href="https://2015.igem.org/Team:Edinburgh/Team">Team</a></li>
 +
                      <li><a href="https://2015.igem.org/Team:Edinburgh/Attributions">Attributions</a></li>
 +
                      <li><a href="https://2015.igem.org/Team:Edinburgh/Collaborations">Collaboration</a></li>
 +
                      <li><a href="https://2015.igem.org/Team:Edinburgh/Sponsors">Sponsors</a></li>
  
 
+
                    </ul>
<body>
+
                   </li>
 
+
<!-- menu -->
+
      <div class="navbar-wrapper">
+
        <div class="container">
+
        <nav class="navbar transparent navbar-default navbar-fixed-top">
+
          <div class="container">
+
            <div class="navbar-header">
+
              <button type="button" class="navbar-toggle collapsed" data-toggle="collapse" data-target="#navbar" aria-expanded="false" aria-controls="navbar">
+
                <span class="sr-only">Toggle navigation</span>
+
                <span class="icon-bar"></span>
+
                <span class="icon-bar"></span>
+
                <span class="icon-bar"></span>
+
              </button>
+
            </div>
+
            <div id="navbar" class="navbar-collapse collapse">
+
              <ul class="nav navbar-nav">
+
                <li class="active">
+
                   <a href="https://2015.igem.org/Team:Edinburgh">Home</a></li>
+
 
                   <li class="dropdown">
 
                   <li class="dropdown">
 
                     <a href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" aria-expanded="false">Project<span class="caret"></span></a>
 
                     <a href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" aria-expanded="false">Project<span class="caret"></span></a>
 
                     <ul class="dropdown-menu" role="menu">
 
                     <ul class="dropdown-menu" role="menu">
                       <li><a href="https://2015.igem.org/Team:Edinburgh/Description">Description</a></li>
+
                       <li><a href="https://2015.igem.org/Team:Edinburgh/Description">Overview</a></li>
                      <li><a href="https://2015.igem.org/Team:Edinburgh/Experiments">Experiments</a> </li>
+
                    <!-- <li><a href="https://2015.igem.org/Team:Edinburgh/Experiments">Experiments</a> </li> -->
                       <li><a href="https://2015.igem.org/Team:Edinburgh/Project/Protocols">Protocols</a> </li>
+
                       <li><a href="https://2015.igem.org/Team:Edinburgh/HeroinBiosensor">Heroin Biosensor</a></li>
                       <li><a href="https://2015.igem.org/Team:Edinburgh/Results">Results</a></li>
+
                      <li><a href="https://2015.igem.org/Team:Edinburgh/DNPBiosensor">DNP Biosensor</a></li>
                       <li><a href="https://2015.igem.org/Team:Edinburgh/Design">Design</a></li>
+
                       <li><a href="https://2015.igem.org/Team:Edinburgh/PMABiosensor">PMA Biosensor</a></li>
 +
                       <li><a href="https://2015.igem.org/Team:Edinburgh/CBD">Making it Stick</a></li>           
 +
                      <li><a href="https://2015.igem.org/Team:Edinburgh/Results">Limits of Detection</a></li>
 
                     </ul>
 
                     </ul>
 
                   </li>
 
                   </li>
Line 41: Line 43:
 
                     <a href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" aria-expanded="false">Parts<span class="caret"></span></a>
 
                     <a href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" aria-expanded="false">Parts<span class="caret"></span></a>
 
                     <ul class="dropdown-menu" role="menu">
 
                     <ul class="dropdown-menu" role="menu">
                       <li><a href="https://2015.igem.org/Team:Edinburgh/Parts">Team Parts</a></li>
+
                       <li><a href="https://2015.igem.org/Team:Edinburgh/Parts">Team Parts</a></li>  
 
                       <li><a href="https://2015.igem.org/Team:Edinburgh/Basic_Part">Basic Parts</a></li>
 
                       <li><a href="https://2015.igem.org/Team:Edinburgh/Basic_Part">Basic Parts</a></li>
 
                       <li><a href="https://2015.igem.org/Team:Edinburgh/Composite_Part">Composite Parts</a></li>
 
                       <li><a href="https://2015.igem.org/Team:Edinburgh/Composite_Part">Composite Parts</a></li>
                       <li><a href="https://2015.igem.org/Team:Edinburgh/Part_Collection">Part Collection</a> </li>
+
                       <li><a href="https://2015.igem.org/Team:Edinburgh/Part_Collection">Part Collection</a> </li>
 +
                      <li><a href="https://2015.igem.org/Team:Edinburgh/Improved_Part">Improved Parts</a></li>
 +
                      <li><a href="https://2015.igem.org/Team:Edinburgh/Characterisation_Part">Improved Characterisation</a></li>
 +
                    </ul>
 +
                  </li>
 +
                  <li class="dropdown">
 +
                    <a href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" aria-expanded="false">Dry Lab<span class="caret"></span></a>
 +
                    <ul class="dropdown-menu" role="menu">
 +
                      <li><a href="https://2015.igem.org/Team:Edinburgh/Modeling">Modeling</a></li>
 +
                      <li><a href="https://2015.igem.org/Team:Edinburgh/Design">Design</a></li>
 +
                      <li><a href="https://2015.igem.org/Team:Edinburgh/Software">Software</a></li>
 
                     </ul>
 
                     </ul>
 
                   </li>
 
                   </li>
                  <li><a href="https://2015.igem.org/Team:Edinburgh/Attributions">Attributions</a></li>
 
 
                   <li class="dropdown">
 
                   <li class="dropdown">
                     <a href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" aria-expanded="false">Policy and Practices<span class="caret"></span></a>
+
                     <a href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" aria-expanded="false">Human Practices<span class="caret"></span></a>
 
                     <ul class="dropdown-menu" role="menu">
 
                     <ul class="dropdown-menu" role="menu">
 
                       <li><a href="https://2015.igem.org/Team:Edinburgh/Practices">Our Story</a></li>
 
                       <li><a href="https://2015.igem.org/Team:Edinburgh/Practices">Our Story</a></li>
 
                       <li><a href="https://2015.igem.org/Team:Edinburgh/Safety">Safety</a> </li>
 
                       <li><a href="https://2015.igem.org/Team:Edinburgh/Safety">Safety</a> </li>
 
                       <li><a href="https://2015.igem.org/Team:Edinburgh/Legality">Legality</a> </li>
 
                       <li><a href="https://2015.igem.org/Team:Edinburgh/Legality">Legality</a> </li>
 +
                      <li><a href="https://2015.igem.org/Team:Edinburgh/Outreach">Outreach</a> </li>
 
                     </ul>
 
                     </ul>
 
                   </li>
 
                   </li>
                  <li><a href="https://2015.igem.org/Team:Edinburgh/Modeling">Modeling</a></li>
 
 
                   <li class="dropdown">
 
                   <li class="dropdown">
 
                     <a href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" aria-expanded="false">InterLab<span class="caret"></span></a>
 
                     <a href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" aria-expanded="false">InterLab<span class="caret"></span></a>
Line 64: Line 75:
 
                     </ul>
 
                     </ul>
 
                   </li>
 
                   </li>
                  <li><a href="software.html">Software</a></li>
 
                  <li><a href="entrepreneurship.html">Entrepreneurship</a></li>
 
                  <li><a href="collaborations.html">Collaborations</a></li>
 
 
                   <li class="dropdown">
 
                   <li class="dropdown">
 
                     <a href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" aria-expanded="false">Notebook<span class="caret"></span></a>
 
                     <a href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" aria-expanded="false">Notebook<span class="caret"></span></a>
 
                     <ul class="dropdown-menu" role="menu">
 
                     <ul class="dropdown-menu" role="menu">
 +
                      <li><a href="https://2015.igem.org/Team:Edinburgh/Project/Protocols">Protocols</a></li>
 
                       <li><a href="https://2015.igem.org/Team:Edinburgh/Notebook/HeroinPurity">Heroin Purity</a></li>
 
                       <li><a href="https://2015.igem.org/Team:Edinburgh/Notebook/HeroinPurity">Heroin Purity</a></li>
 
                       <li><a href="https://2015.igem.org/Team:Edinburgh/Notebook/PMADetection">PMA Detection</a> </li>
 
                       <li><a href="https://2015.igem.org/Team:Edinburgh/Notebook/PMADetection">PMA Detection</a> </li>
Line 76: Line 85:
 
                     </ul>
 
                     </ul>
 
                   </li>
 
                   </li>
                </ul>
+
                  <li><a href="https://2015.igem.org/Team:Edinburgh/MedalCriteria">Accomplishments</a></li>  
              </div>
+
            </ul>
            </div>
+
          </nav>
+
 
         </div>
 
         </div>
      </div>
+
    </div>
 +
</div>
 +
 
 +
 
 
     <!-- End of menu  -->
 
     <!-- End of menu  -->
  
 +
<body>
 
       <header class="intro">
 
       <header class="intro">
 
         <div class="intro-body">
 
         <div class="intro-body">
Line 89: Line 100:
 
             <div class="row">
 
             <div class="row">
 
               <div class="col-md-12">
 
               <div class="col-md-12">
                 <h1 class="brand-heading">Design</h1>
+
                 <h1 class="brand-heading">Overview</h1>
 
                 <p class="intro-text">
 
                 <p class="intro-text">
 
<br>
 
<br>
 
<br>
 
<br>
 
<br>
 
<br>
 +
 
                 </p>
 
                 </p>
 +
                <a href="#content">
 +
                        <span class="arrowtext">Scroll down to read more</span>
 +
                        <img src="https://static.igem.org/mediawiki/2014/3/3e/Aalto_Helsinki_Nuoli.png" class="arrow">
 +
                    </a>
 
               </div>
 
               </div>
 
             </div>
 
             </div>
Line 101: Line 117:
 
       </header>
 
       </header>
  
      <section class="ss-style-halfcircle">
+
<section id="content">
<h2>Our Hypothesis</h2>
+
        <section class="ss-style-bigtriangle">
                <p>
+
              <h2>Introduction: A Cell-free, Paper-based Biosensor</h2>
We believe that drug testing kits should be safe, affordable, and readily available to those at risk.  
+
                  <p>
 +
We think drug testing kits should be safe, affordable, and readily available to those at risk. Where tests are affordable and understandable to the end-user, accuracy, and thus safety, is compromised. It is clear that the current methods for checking drugs are not adequate. To change this we envisioned a test designed and modeled around the fundamental needs of the users. This is a test built from their personal input and experience, to create the most useful and appropriate device possible. 
 
<br>
 
<br>
 
<br>
 
<br>
Where tests are affordable and understandable to the end-user, accuracy, and thus safety, is compromised. It is clear that the current methods for checking drugs are not adequate. To change this we envisioned a test designed and modelled around the fundamental needs of the users. This is a test built from their personal input and experience, to create the most useful and appropriate device possible.
+
The current methods available for home testing of drug samples consist of chemical-based tests. One of the main suppliers of these kinds of tests is EZ Test Kits, who produce everything from tests for cocaine purity to testing for the presence of certain cannabinoids. While these tests are a very important resource, they have two main flaws. Firstly, the detection relies on interpreting a subjective colour change by eye, and secondly that each test is specific for one compound only. There are other very accurate methods used to test drug samples. These include mass spectrometry and other tests which use gas chromatography and infrared spectroscopy. Since these testing methods are expensive and not portable they cannot be used as a home testing method, and are instead incorporated in the police and border agencies enforcement.  
 
<br>
 
<br>
 
<br>
 
<br>
We see an opportunity for synthetic biology to provide us with the winning combination of accuracy, ease of use, adaptability, low-cost and portability - a mix that neither simple chemical test-kits nor high-end analytical chemistry can provide. Synthetic biology has allowed us to present the best aspects of all the existing methodologies in one simple device, creating a feasible method of getting accurate safety information to all those who need it.  
+
The utilization of a cell-free system was the most appropriate choice for this project, for it was conducive to the biosensor being used outside of the laboratory in a safe and effective manner. Indeed, it is paramount that users of the biosensor are not exposed to potential pathogens, and that that the environment is protected against the accidental release of genetically modified organisms. Since our device is intended to be used primarily by people with little or no training, the best way to provide this level of safety and security was to ensure that no live organisms were incorporated in the test.
 
<br>
 
<br>
 
<br>
 
<br>
Through hard work, innovative thinking, strong end-user engagement and of course a hefty dose of synthetic biology, we embarked on a mission to use synthetic biology to make a difference.  
+
Avoiding the use of live organisms also allows for a degree of portability, for regulation would have otherwise hindered the implementation in non-laboratory environments, including the environments in which we intend to employ the device (see p&p for more - link to our story). Furthermore, there would be a long and costly legal process to get our biosensor the green light if it were to utilize genetically modified organisms.  
                </p>
+
<br>
      </section>
+
<br>
      <section class="color ss-style-bigtriangle">
+
The choice of a paper-based biosensor was also fundamental to its ability to compete on the free market, as this reduced the estimated cost to no more than 10 pence per test paper<sup>1</sup>.
                  <p>
+
 
Another big part of our design process was trying to computationally model how our biosensor will behave and helping us understand where are design might lack. Our early conversations made us realise for our biosensor to be better than the current methods , it will have to be easy to use, portable cheap to manufacture and having it paper based was the answer to that.
+
 
 
         </p>
 
         </p>
 
       </section>
 
       </section>
       <section class="col-2 ss-style-doublediagonal">
+
       <section class="color col-2 ss-style-halfcircle">
 
         <div class="column">
 
         <div class="column">
          <span class="icon icon-images">
+
            <img class="img-responsive" src="https://static.igem.org/mediawiki/2015/6/61/Edigem15_Overvirew_genesorenzymes.jpeg">
            <img src="whiteneedle2.png">
+
          </span>
+
 
         </div>
 
         </div>
 
         <div class="column text">
 
         <div class="column text">
           <h2>Prototype 1</h2>
+
           <h2>Enzymes or Genes?</h2>
 
           <p>
 
           <p>
Once we decided on to use paper-based biosensor we set out to talk to more people. //link A talk with Susan Deacon made us realise we will need to have multiple tests on one strip, That’s when we found inspiration in the design made by //reference *George Whiteside’s lab for a glucose biosensor*. In this design we would have channels of paper where water will diffuse separated by a hydrophobic material like wax or plastics.
+
In the earliest stages of design, we contemplated using gene networks to operate our detection system; however, our human practices research quickly led us to re-evaluate this decision. Through conversations with our end users, as well as professionals working directly with the users, we quickly learnt that users would be seriously deterred from using the sensor if they were subjected to long waiting-times for results. Thus, it became clear that minimising time-to-detection was a priority for our design, and that using an enzyme system, with its increased speed of detection and stability compared to gene networks, was the best method to meet this criterion.
          </p>
+
 
          <p>
+
But there was one problem with this design, The distribution of the solution was not uniform #which really created some problems.
+
 
           </p>
 
           </p>
 
         </div>
 
         </div>
 
       </section>
 
       </section>
       <section class="color ss-style-bigtriangle" >
+
       <section class="col-2 ss-style-bigtriangle" >
         <h2>Prototype 2 </h2>
+
          
        <p>
+
        <div class="column text">
We brainstormed and tried to make our biosensor a bit more simple so that we could have uniform distribution throughout the strip and we came up with this design. This strip would have been of the size of a microscope slide. The Strips you see in centre of the biosensor would again be kept apart by a hydrophobic material and the biosensor would be places inside them.
+
            <h2>Producing the Enzymes</h2>
      </p>
+
            <p>
      <p>
+
In order to decrease the cost of the biosensor, we decided not to purify the enzymes, because this is both a tedious and expensive process. Instead, we will place crude cell lysate on each of the bioactive zones. By transforming the plasmids in the chassis <i>Escherichia coli</i> BL21 (DE3), we can increase enzyme production. This is a result of it being a robust and non-pathogenic <i>E. coli</i> B strain able to grow vigorously in minimal media in comparison to the Top10s we completed our cloning in. It is also deficient in ompT and lon; two proteases that could cause problems with protein isolation<sup>2</sup>. 
Although this design meant we could easily predict the diffusion of the liquid as it was all uniform, it did not do well in concentrating the colour produced at one place. It was just too spread out.
+
<br>
//Modelling movie
+
<br>
      </p>
+
All protein expression is under the control of the lactose induced expression cassette (BBa_K314103) produced by iGEM10_Washington. This expression cassette includes a LacI generator and a lactose inducible promoter with the Elowitz standard RBS. By putting the lac operon in front of the enzyme coding sequence, we should be able to regulate transcription of the gene via production of the LacI repressor protein. IPTG, an analogue of lactose, can be used to induce protein expression<sup>3</sup>. Having a repressible promoter is key in situations where the proteins can be toxic to the cells in high concentrations<sup>4</sup>.
 +
<br>
 +
            </p>
 +
        </div>
 +
        <div class="column">
 +
            <img src="https://static.igem.org/mediawiki/2015/c/cb/Edigem15_Overvirew_producingtheemzymes.jpeg" class="img-responsive icon">
 +
        </div>
 
       </section>
 
       </section>
         <section class="col-2 ss-style-doublediagonal">
+
         <section class="color col-2 ss-style-halfcircle">
 
         <div class="column">
 
         <div class="column">
 
           <span class="icon icon-images">
 
           <span class="icon icon-images">
             <img src="whiteneedle.png">
+
             <img src="https://static.igem.org/mediawiki/2015/1/1f/Edigem15_Overvirew_immobilisation.jpeg" class="img-responsive icon">
 
           </span>
 
           </span>
 
         </div>
 
         </div>
 
         <div class="column text">
 
         <div class="column text">
           <h2>Prototype 3 </h2>
+
           <h2>Immobilising the Enzymes</h2>
 
           <p>
 
           <p>
With the help of our modelling efforts it did not take us long come up with a new solution. Just make some cavities in the design we had that would contain the colour produced.
+
After considering the large amount of diffusion of the crude cell lysate through the paper, we thought about methods to immobilise the enzymes so they remain in the intended bioactive zones. This led us to fusing our enzymes to Cellulose Binding Domains (CBDs) to ensure the enzymes would stick to the paper.
          </p>
+
<br>
 +
<br>
 +
CBDs are proteins that recognise and bind specifically to polysaccharides, such as cellulose<sup>5</sup>. Their advantages include: the fact that they are independent folding units, having inexpensive and abundant attachment matrices and, most importantly, having controllable binding affinities<sup>6</sup>. This means that we can make sure enzymes that work at different speeds are fused to the CBD with an appropriate binding affinity in order to give the optimal concentration of enzyme on paper. This also allows an inexpensive purification method by washing the paper with PBS after being incubated with the crude lysate as only the CBD fusions will remain on the paper.
 +
<br>
 +
        </p>
 +
      </section>
 +
        <section class="col-2 ss-style-bigtriangle">
 +
        <div class="column text">
 +
          <h2>RFC10 vs RFC25</h2>
 
           <p>
 
           <p>
At this time we really did think we had a winner, but //link talking to more experts made us realise  somewhere we could push ourself even more. Reducing the amount of liquid used as the end users might not want to waste a lot of their drug. Although this design only used about 150µl of solution we felt we could do better
+
        One of the goals of our biosensor is to make it a proof of concept for future biosensors with interchangeable parts. This requires us to think about how every enzyme and CBD can be exchanged for a different enzyme or CBD. This standardisation was started with the BioBrick assembly method, such that every part has complementary terminals. The original BioBrick assembly method (RFC10), however, does not allow for the construction of protein fusions, as there is an 8-nucleotide scar between the two genes leaving a frameshift mutation<sup>7</sup>.  
 +
<br>
 +
<br>
 +
This led us to use the Freiburg format of RFC25 since everything we did relied on protein fusions. RFC25 is compatible with all existing parts in RFC10 and only leaves a 6-nucleotide scar, which allows the genes to stay in frame. The RFC25 prefix and suffix required certain restriction sites to not be in the gene to allow for fusions<sup>8</sup>. It also meant that our protein-coding genes could be in frame in a single plasmid so they will produce fused, functional proteins when transcribed.
 +
 
           </p>
 
           </p>
 +
        </div>
 +
        <div class="column">
 +
            <img src="https://static.igem.org/mediawiki/2015/2/2e/RFC10_vs_RFC25.jpeg" class="img-responsive icon">
 
         </div>
 
         </div>
 
       </section>
 
       </section>
       <section class="color ss-style-bigtriangle">
+
       <section class="color ss-style-halfcircle">
         <h2>Final Biosensor Design</h2>
+
         <h2>Freeze drying</h2>
 
         <p>
 
         <p>
At this time we looked at some our older designs and that when we came up with our current design. This strip only required a tenth of the solution we were using before Uniform distribution, concentrated colours and minimalistic liquid requirements, it has it all.
+
The final step in creating our biosensor is ensuring its mobility. This is done by freeze-drying all of the enzymes on paper. This process increases stability and shelf-life of enzymes so that freshness, and therefore reliability, of the biosensors is not compromised. It further involves freezing the sample, as well as two subsequent stages of drying<sup>9</sup>. Freeze-drying with 20% trehalose is a method of further increasing the stability of the enzymes<sup>10</sup>.
        </p>
+
 
        <p>
+
We were not done yet though, //link A talk with Adam Winstoke gave us the idea that we could increase the ease of use and reliability of results by making a smartphone application and we set out a goal to make that happen
+
 
         </p>
 
         </p>
 +
        </div>
 
       </section>
 
       </section>
 
+
       <section class="col-2 ss-style-bigtriangle">
       <section class="col-2 ss-style-doublediagonal">
+
      <div class="column">
        <div class="column">
+
 
           <span class="icon icon-images">
 
           <span class="icon icon-images">
             <img src="whiteneedle.png">
+
             <img src="https://static.igem.org/mediawiki/2015/4/47/Edigem15_Overvirew_adaptable.jpeg" class="img-responsive icon">
 
           </span>
 
           </span>
 
         </div>
 
         </div>
 
         <div class="column text">
 
         <div class="column text">
          <h2>Completing the Device</h2>
+
        <h2>An adaptable design</h2>
          <p>
+
        <p>
As soon as we started thinking on this idea we realised there were some hurdles that had to be overcome. For the results to be accurate the picture had to be in a fixed position. Also we needed to control the amount of light that the photo is taken in. The camera had to be positioned at a height more than the minimum focal length as well. At the same time we had to be true to our original intentions of ease of use, cost-effectiveness and portability.  
+
Whilst Edinburgh iGEM 2015’s biosensor may leave a great legacy in improving drug safety, we hope the impact it has does not end there. Our biosensor is a fluid and adaptable model that can be easily manipulated to serve a range of analytical purposes, bringing synthetic biology to the forefront of detection sciences.
          </p>
+
<br>
 +
<br>
 +
Through exchange of standard biological parts, the device can easily be produced with different enzymes by switching the genes in our backbone. This allows our biosensor to be important not only as a harm reduction tool for drug users, but as a proof of concept with much wider applications. Exchanging the enzymes in the biosensor could allow for our device to test for a multitude of compounds, be they drugs, contaminants or counterfeit-pharmaceuticals. (Find out more in Future Applications- link to future applications).
 +
<br>
 +
<br>
 +
Our device is far more than a tool to improve the safety of a small group of user; its user-targeted design and enhanced biosafety allows our biosensor to bring synthetic biology out of the lab and into society in ways that have not been possible before.  
 +
 
 +
        </p>
 +
 
 +
            <div align="center">
 +
                <a href="https://2015.igem.org/Team:Edinburgh/Characterisation_Part" class="btn btn-primary btn-lg outline" role="button">Improved Characterisation</a>
 +
            </div>
  
 
         </div>
 
         </div>
 
       </section>
 
       </section>
        <section class="ss-style-bigtriangle">
+
      <section class="color ss-style-halfcircle">
 +
        <h2>References</h2>
 
         <p>
 
         <p>
<br>
+
<sup>1</sup> Pelton, R. (2009) Bioactive Paper Provides Low Cost Platform for Diagnostics. <i>Trends in Analytical Chemistry</i>, 28(8), 925-942.
 +
<br><sup>2</sup> Chart, H., Smith, H. R., La Ragione, R. M., & Woodward, M. J. (2000). An investigation into the pathogenic properties of Escherichia coli strains BLR, BL21, DH5α and EQ1. <i>Journal of applied microbiology</i>, 89(6), 1048-1058.
 +
<br><sup>3</sup> K.S. Matthews, J.C. Nichols (1998). Lactose repressor protein: functional properties and structure. <i>Prog Nucleic Acid Res Mol Biol</i>, 58, 127–164
 +
<br><sup>4</sup> O'Connor, C. D., & Timmis, K. N. (1987). Highly repressible expression system for cloning genes that specify potentially toxic proteins. <i>Journal of bacteriology</i>, 169(10), 4457-4462.
 +
<br><sup>5</sup> Boraston, A. B., Bolam, D., Gilbert, H., & Davies, G. J. G. J. (2004). Carbohydrate-binding modules: fine-tuning polysaccharide recognition. <i>Biochem. J</i>, 382, 769-781.
 +
<br><sup>6</sup> Bayer, E. A., Morag, E., & Lamed, R. (1994). The cellulosome—a treasure-trove for biotechnology. <i>Trends in biotechnology</i>, 12(9), 379-386.
 +
<br><sup>7</sup> Anderson, J., Dueber, J. E., Leguia, M., Wu, G. C., Goler, J. A., Arkin, A. P., & Keasling, J. D. (2010). BglBricks: A flexible standard for biological part assembly. <i>Journal of biological engineering</i>, 4(1), 1-12.
 +
<br><sup>8</sup> Grünberg, R., Ferrar, T. S., van der Sloot, A. M., Constante, M., & Serrano, L. (2010). Building blocks for protein interaction devices. <i>Nucleic acids research</i>, gkq152.
 +
<br><sup>9</sup> Roy, I., & Gupta, M. N. (2004). Freeze‐drying of proteins: some emerging concerns. <i>Biotechnology and applied biochemistry</i>, 39(2), 165-177.
 +
<br><sup>10</sup> Mazzobre, M. F., & Buera, M. D. P. (1999). Combined effects of trehalose and cations on the thermal resistance of β-galactosidase in freeze-dried systems. <i>Biochimica Et Biophysica Acta (BBA)-General Subjects</i>, 1473(2), 337-344.
 +
 
 
         </p>
 
         </p>
      </section>
+
</section>
 +
</section>
  
   
 
 
</div>
 
 
</body>
 
</body>
 
</html>
 
</html>

Latest revision as of 19:02, 20 November 2015

Introduction: A Cell-free, Paper-based Biosensor

We think drug testing kits should be safe, affordable, and readily available to those at risk. Where tests are affordable and understandable to the end-user, accuracy, and thus safety, is compromised. It is clear that the current methods for checking drugs are not adequate. To change this we envisioned a test designed and modeled around the fundamental needs of the users. This is a test built from their personal input and experience, to create the most useful and appropriate device possible.

The current methods available for home testing of drug samples consist of chemical-based tests. One of the main suppliers of these kinds of tests is EZ Test Kits, who produce everything from tests for cocaine purity to testing for the presence of certain cannabinoids. While these tests are a very important resource, they have two main flaws. Firstly, the detection relies on interpreting a subjective colour change by eye, and secondly that each test is specific for one compound only. There are other very accurate methods used to test drug samples. These include mass spectrometry and other tests which use gas chromatography and infrared spectroscopy. Since these testing methods are expensive and not portable they cannot be used as a home testing method, and are instead incorporated in the police and border agencies enforcement.

The utilization of a cell-free system was the most appropriate choice for this project, for it was conducive to the biosensor being used outside of the laboratory in a safe and effective manner. Indeed, it is paramount that users of the biosensor are not exposed to potential pathogens, and that that the environment is protected against the accidental release of genetically modified organisms. Since our device is intended to be used primarily by people with little or no training, the best way to provide this level of safety and security was to ensure that no live organisms were incorporated in the test.

Avoiding the use of live organisms also allows for a degree of portability, for regulation would have otherwise hindered the implementation in non-laboratory environments, including the environments in which we intend to employ the device (see p&p for more - link to our story). Furthermore, there would be a long and costly legal process to get our biosensor the green light if it were to utilize genetically modified organisms.

The choice of a paper-based biosensor was also fundamental to its ability to compete on the free market, as this reduced the estimated cost to no more than 10 pence per test paper1.

Enzymes or Genes?

In the earliest stages of design, we contemplated using gene networks to operate our detection system; however, our human practices research quickly led us to re-evaluate this decision. Through conversations with our end users, as well as professionals working directly with the users, we quickly learnt that users would be seriously deterred from using the sensor if they were subjected to long waiting-times for results. Thus, it became clear that minimising time-to-detection was a priority for our design, and that using an enzyme system, with its increased speed of detection and stability compared to gene networks, was the best method to meet this criterion.

Producing the Enzymes

In order to decrease the cost of the biosensor, we decided not to purify the enzymes, because this is both a tedious and expensive process. Instead, we will place crude cell lysate on each of the bioactive zones. By transforming the plasmids in the chassis Escherichia coli BL21 (DE3), we can increase enzyme production. This is a result of it being a robust and non-pathogenic E. coli B strain able to grow vigorously in minimal media in comparison to the Top10s we completed our cloning in. It is also deficient in ompT and lon; two proteases that could cause problems with protein isolation2.

All protein expression is under the control of the lactose induced expression cassette (BBa_K314103) produced by iGEM10_Washington. This expression cassette includes a LacI generator and a lactose inducible promoter with the Elowitz standard RBS. By putting the lac operon in front of the enzyme coding sequence, we should be able to regulate transcription of the gene via production of the LacI repressor protein. IPTG, an analogue of lactose, can be used to induce protein expression3. Having a repressible promoter is key in situations where the proteins can be toxic to the cells in high concentrations4.

Immobilising the Enzymes

After considering the large amount of diffusion of the crude cell lysate through the paper, we thought about methods to immobilise the enzymes so they remain in the intended bioactive zones. This led us to fusing our enzymes to Cellulose Binding Domains (CBDs) to ensure the enzymes would stick to the paper.

CBDs are proteins that recognise and bind specifically to polysaccharides, such as cellulose5. Their advantages include: the fact that they are independent folding units, having inexpensive and abundant attachment matrices and, most importantly, having controllable binding affinities6. This means that we can make sure enzymes that work at different speeds are fused to the CBD with an appropriate binding affinity in order to give the optimal concentration of enzyme on paper. This also allows an inexpensive purification method by washing the paper with PBS after being incubated with the crude lysate as only the CBD fusions will remain on the paper.

RFC10 vs RFC25

One of the goals of our biosensor is to make it a proof of concept for future biosensors with interchangeable parts. This requires us to think about how every enzyme and CBD can be exchanged for a different enzyme or CBD. This standardisation was started with the BioBrick assembly method, such that every part has complementary terminals. The original BioBrick assembly method (RFC10), however, does not allow for the construction of protein fusions, as there is an 8-nucleotide scar between the two genes leaving a frameshift mutation7.

This led us to use the Freiburg format of RFC25 since everything we did relied on protein fusions. RFC25 is compatible with all existing parts in RFC10 and only leaves a 6-nucleotide scar, which allows the genes to stay in frame. The RFC25 prefix and suffix required certain restriction sites to not be in the gene to allow for fusions8. It also meant that our protein-coding genes could be in frame in a single plasmid so they will produce fused, functional proteins when transcribed.

Freeze drying

The final step in creating our biosensor is ensuring its mobility. This is done by freeze-drying all of the enzymes on paper. This process increases stability and shelf-life of enzymes so that freshness, and therefore reliability, of the biosensors is not compromised. It further involves freezing the sample, as well as two subsequent stages of drying9. Freeze-drying with 20% trehalose is a method of further increasing the stability of the enzymes10.

An adaptable design

Whilst Edinburgh iGEM 2015’s biosensor may leave a great legacy in improving drug safety, we hope the impact it has does not end there. Our biosensor is a fluid and adaptable model that can be easily manipulated to serve a range of analytical purposes, bringing synthetic biology to the forefront of detection sciences.

Through exchange of standard biological parts, the device can easily be produced with different enzymes by switching the genes in our backbone. This allows our biosensor to be important not only as a harm reduction tool for drug users, but as a proof of concept with much wider applications. Exchanging the enzymes in the biosensor could allow for our device to test for a multitude of compounds, be they drugs, contaminants or counterfeit-pharmaceuticals. (Find out more in Future Applications- link to future applications).

Our device is far more than a tool to improve the safety of a small group of user; its user-targeted design and enhanced biosafety allows our biosensor to bring synthetic biology out of the lab and into society in ways that have not been possible before.

References

1 Pelton, R. (2009) Bioactive Paper Provides Low Cost Platform for Diagnostics. Trends in Analytical Chemistry, 28(8), 925-942.
2 Chart, H., Smith, H. R., La Ragione, R. M., & Woodward, M. J. (2000). An investigation into the pathogenic properties of Escherichia coli strains BLR, BL21, DH5α and EQ1. Journal of applied microbiology, 89(6), 1048-1058.
3 K.S. Matthews, J.C. Nichols (1998). Lactose repressor protein: functional properties and structure. Prog Nucleic Acid Res Mol Biol, 58, 127–164
4 O'Connor, C. D., & Timmis, K. N. (1987). Highly repressible expression system for cloning genes that specify potentially toxic proteins. Journal of bacteriology, 169(10), 4457-4462.
5 Boraston, A. B., Bolam, D., Gilbert, H., & Davies, G. J. G. J. (2004). Carbohydrate-binding modules: fine-tuning polysaccharide recognition. Biochem. J, 382, 769-781.
6 Bayer, E. A., Morag, E., & Lamed, R. (1994). The cellulosome—a treasure-trove for biotechnology. Trends in biotechnology, 12(9), 379-386.
7 Anderson, J., Dueber, J. E., Leguia, M., Wu, G. C., Goler, J. A., Arkin, A. P., & Keasling, J. D. (2010). BglBricks: A flexible standard for biological part assembly. Journal of biological engineering, 4(1), 1-12.
8 Grünberg, R., Ferrar, T. S., van der Sloot, A. M., Constante, M., & Serrano, L. (2010). Building blocks for protein interaction devices. Nucleic acids research, gkq152.
9 Roy, I., & Gupta, M. N. (2004). Freeze‐drying of proteins: some emerging concerns. Biotechnology and applied biochemistry, 39(2), 165-177.
10 Mazzobre, M. F., & Buera, M. D. P. (1999). Combined effects of trehalose and cations on the thermal resistance of β-galactosidase in freeze-dried systems. Biochimica Et Biophysica Acta (BBA)-General Subjects, 1473(2), 337-344.